Last reviewed · How we verify
Intravesical Onabotulinum Toxin A Injection — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Intravesical Onabotulinum Toxin A Injection (Intravesical Onabotulinum Toxin A Injection) — Bagcilar Training and Research Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intravesical Onabotulinum Toxin A Injection TARGET | Intravesical Onabotulinum Toxin A Injection | Bagcilar Training and Research Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intravesical Onabotulinum Toxin A Injection CI watch — RSS
- Intravesical Onabotulinum Toxin A Injection CI watch — Atom
- Intravesical Onabotulinum Toxin A Injection CI watch — JSON
- Intravesical Onabotulinum Toxin A Injection alone — RSS
Cite this brief
Drug Landscape (2026). Intravesical Onabotulinum Toxin A Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/intravesical-onabotulinum-toxin-a-injection. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab